Immunology

This study shows that 10% of patients with severe COVID-19 have neutralising antibodies against the cytokine interferon type 1.

This study aims to determine whether the neutrophil-to-lymphocyte ratio (NLR) can be useful in the diagnosis and treatment of COVID-19.

The RIM score, a simple and widely available tool that can help identify patients at risk of fatal COVID-19 outcomes.

Identifying true markers of protective immunity will allow for the identification of individuals, in particular healthcare personnel working with COVID-19 patients and in other critical areas protected from re-infection.

This study aims to determine the differences in the evolution of the immune response in the months following SARS-CoV-2 infection in men and women.

Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.

This study analyses if patients with autoimmune diseases and coronavirus infection have a lower risk of developing severe COVID.

Are you immunosuppressed? Engage this study and help underestand the kinetics of adaptive immunization against COVID-19.

This study aims to better understand the functioning of the immune response to SARS CoV-2 in order to propose new treatments based on the body’s cellular response to COVID-19.